4D Molecular Therapeutics Inc
NASDAQ:FDMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
I
|
I-Tail PCL Corp
SET:ITC
|
TH |
|
First Business Financial Services Inc
F:45D
|
US |
|
U
|
Ulta Beauty Inc
LSE:0LIB
|
US |
|
E
|
Eastman Chemical Co
DUS:EAC
|
US |
|
T
|
Tyson Foods Inc
XMUN:TF7A
|
US |
|
I
|
Interface Inc
F:IF6N
|
US |
|
P
|
Pebble Beach Systems Group PLC
F:VSF
|
UK |
|
G
|
Glaukos Corp
F:6GJ
|
US |
|
M
|
Medallion Financial Corp
F:MD5
|
US |
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
B
|
Bayerische Motoren Werke AG
MIL:BMW
|
DE |
|
K
|
Kellogg Co
F:KEL
|
US |
|
U
|
UBE Corp
F:UBE
|
JP |
|
SB Financial Group Inc
F:9KH
|
US |
|
R
|
Reach PLC
F:MRR
|
UK |
Shareholder Yield
Current shareholder yield for FDMT is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
FDMT Price
4D Molecular Therapeutics Inc
| Average Annual Return | -27.63% |
| Standard Deviation of Annual Returns | 33.3% |
| Max Drawdown | -93% |
| Market Capitalization | 826.6m USD |
| Shares Outstanding | 52 280 000 |
| Percentage of Shares Shorted | 28.59% |
